Home / Stocks / K M C Speciality Hosp I L
KMCSHIL

K M C Speciality Hosp I L Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹201.64

Change

+4.22 (2.14%)

Open

₹197.42

Prev. Close

₹197.42

Day High

₹203.5

Day Low

₹194.38

Volume Analysis

Traded

1,373,856

Delivered

185,816

Delivery %

13.53%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (2)

  • •High overall fundamentals quality score (80/100)
  • •Strong operating margin (29.0%)

Weaknesses (0)

No signal for this stock

Opportunities (2)

  • •Strong 3-year EPS growth (20.5%)
  • •Strong 3-year revenue growth (25.2%)

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹214.42 ₹208.96 ₹205.3 ₹199.84 ₹196.18 ₹190.72 ₹187.06
Fibonacci ₹208.96 ₹205.48 ₹203.32 ₹199.84 ₹196.36 ₹194.2 ₹190.72
Camarilla ₹204.15 ₹203.31 ₹202.48 ₹199.84 ₹200.8 ₹199.97 ₹199.13

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

—

1 Week

+14.29%

1 Month

+34.38%

3 Months

+42.35%

6 Months

—

1 Year

—

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

DuPont ROE Breakdown

19.41%

Net margin 15.36% × asset turnover 0.81x × equity multiplier 1.56x

Company Overview

Sector

Healthcare

Source: Screener.in (Consolidated figures) — data as of 16 Nov 2026. Not investment advice.

TopFund Analysis

K M C Speciality Hosp I L scores strongly on TopFund's composite fundamentals check within the Healthcare sector, at 80/100. The strongest factor is Growth (100/100), while Institutional Ownership (30/100) is the weakest area to weigh before deciding. Notably: High overall fundamentals quality score (80/100); strong operating margin (29.0%). Strong 3-year EPS growth (20.5%).

TopFund Score — Fundamentals Quality

80/100 — Excellent

Data confidence: 71/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

96

Growth

100

Cash Flow

100

Corporate Governance

56

Institutional Ownership

30

Business Quality

92

Risk & Volatility

68

Liquidity

50

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Newspaper publication regarding Special Window for transfer and dematerialisation of physical shares of the Company.

Holding company rectified disclosure discrepancies for transactions dated 04/08/2026 and 04/09/2026.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 (S) Dec 2023 (S) Mar 2024 (S) Jun 2024 (S) Sep 2024 (S) Dec 2024 (S) Mar 2025 (S) Jun 2025 (S) Sep 2025 (S) Dec 2025 (S) Mar 2026 (S) Jun 2026 (S) Sep 2026 (S)
Sales + 42 49 45 53 56 61 61 67 75 82 82 92 93
Expenses + 31 35 33 40 44 45 46 50 54 57 56 63 65
Operating Profit 11 14 12 13 13 16 15 16 21 25 26 28 28
OPM % 26.0% 29.0% 26.0% 24.0% 22.0% 26.0% 25.0% 25.0% 28.0% 30.0% 31.0% 31.0% 30.0%
Other Income + 1 1 1 1 0 1 1 1 1 1 2 2 1
Interest 0 0 0 2 3 2 2 2 2 2 2 2 2
Depreciation 2 2 3 4 5 5 5 5 5 5 6 6 6
Profit before tax 9 12 9 7 5 10 9 10 15 18 20 22 22
Tax % 26.0% 24.0% 25.0% 26.0% 27.0% 25.0% 49.0% 25.0% 26.0% 26.0% 26.0% 26.0% 25.0%
Net Profit + 7 9 7 6 4 8 5 8 11 14 15 17 16
EPS in Rs 0 1 0 0 0 0 0 0 1 1 1 1 1
Raw PDF — — — — — — — — — — — — —
YoY Sales growth 7 23 9 30 33 25 36 25 33 34 35 38 24

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S)
Sales + 36 43 55 71 82 96 103 136 156 177 232 306
Expenses + 31 35 42 56 66 75 79 99 114 129 174 217
Operating Profit 6 8 12 14 16 21 23 37 42 48 57 88
OPM % 16.0% 19.0% 23.0% 20.0% 20.0% 22.0% 23.0% 28.0% 27.0% 27.0% 25.0% 29.0%
Other Income + 0 1 0 0 2 1 2 2 3 4 3 5
Interest 2 2 1 1 1 1 1 1 1 2 10 9
Depreciation 4 3 3 4 4 5 6 7 8 9 19 22
Profit before tax 0 4 8 10 12 17 18 32 36 41 32 63
Tax % 0.0% 21.0% 33.0% 32.0% 30.0% 30.0% 29.0% 26.0% 26.0% 25.0% 32.0% 26.0%
Net Profit + 0 3 5 7 9 12 13 24 27 30 21 47
EPS in Rs 0 0 0 0 1 1 1 1 2 2 1 3
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Sales growth 14 17 29 29 16 17 7 33 14 14 31 32

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S) Sep 2026 (S)
Reserves -6 -3 8 14 23 34 47 70 97 127 148 194 227
Borrowings + 14 10 6 15 10 9 29 29 50 82 89 84 89
Other Liabilities + 7 6 8 8 10 11 13 13 18 38 32 38 47
Total Liabilities 31 29 38 53 60 70 105 129 182 264 286 332 379
Fixed Assets + 25 23 24 37 36 39 74 75 84 206 248 248 253
CWIP 0 0 0 0 0 0 2 6 34 1 0 0 3
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Assets + 6 7 14 16 24 31 29 48 63 57 38 84 124
Total Assets 31 29 38 53 60 70 105 129 182 264 286 332 379
Equity Capital 16 16 16 16 16 16 16 16 16 16 16 16 16

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S)
Cash from Operating Activity + 5 6 10 12 16 11 26 29 32 38 58 79
Cash from Investing Activity + -1 -1 -4 -19 -9 -8 -43 -29 -48 -56 -51 -17
Cash from Financing Activity + -5 -5 -5 6 -5 -4 18 -1 16 20 -2 -21
Net Cash Flow 0 0 1 -1 1 -1 1 0 0 3 4 41
Free Cash Flow 5 5 6 -3 13 7 -15 16 -12 -37 -6 63
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 112 91 94 100 113 66 120 102 100 101 112 99

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 75.0% → 75.0%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 25.0% 25.0% 24.99% 24.98% 25.0% 25.0% 25.0% 25.0% 24.99% 25.01% 24.98% 24.98%
Promoters 75.0% 75.0% 75.0% 75.0% 75.0% 75.0% 75.0% 75.0% 75.0% 75.0% 75.0% 75.0%
FII 0.0% 0.0% 0.0% 0.0% 0.0% 0.01% 0.0% 0.0% 0.0% 0.0% 0.02% 0.03%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
K M C Speciality Hosp I L (this stock) — — — —
Sun Pharmaceutical Ind L 451,075 36.7 5.05 16.0%
Divi S Laboratories Ltd 294,139 86.1 16.34 16.5%
Torrent Pharmaceuticals L 177,632 81.8 9.67 27.4%
Apollo Hospitals Enter. L 125,893 55.6 11.86 21.5%
Laurus Labs Limited 125,380 93.6 20.73 18.3%
Zydus Lifesciences Ltd 118,693 26.2 4.27 21.2%

Which Mutual Funds Hold K M C Speciality Hosp I L?

Frequently Asked Questions about K M C Speciality Hosp I L

Community Sentiment

What are other investors saying about K M C Speciality Hosp I L?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.